Stock Trend Analysis Report
Prepared for you on Wednesday, December 6, 2023.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK)
Countertrend Up (+85) - MACK is showing short-term weakness. However, look for the longer-term bullish trend to resume. As always, continue to monitor the trend score and utilize a stop order.
Is it time to buy, sell, or avoid MACK?
MarketClub looks at technical strength and momentum to determine if the timing is right for MACK.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for MACK
The long-term trend has been UP since Nov 15th, 2023 at 12.62
The intermediate-term trend has been UP since Nov 15th, 2023 at 12.55
The short-term trend has been DOWN since Nov 28th, 2023 at 12.77
Smart Scan Analysis for MACK
Based on our trend formula, MACK is rated as a +85 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||11.7||Year High Date||2018-03-09|
|Year Low||3.3401||Year Low Date||2018-10-19|
|52wk High||13.15||52wk High Date||2023-05-10|
|52wk Low||10.1||52wk Low Date||2022-12-22|
|Year End Close||6.09||Average Volume||42,493|
|Shares Outstanding||14,321||Short Interest||3,605,567|
|% Institutional||47.8||Market Cap||80M|